Delivery Order SPE2DB22D2108-SPE2DB25FU5TC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lidocaine 5% patches (30-count units) with a ceiling value of $2,734.80. This is a firm fixed price, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed price delivery order has a ceiling value of $3,425.36 and is scheduled for ultimate completion by July 23, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $2,431.20. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a routine pharmaceutical procurement supporting federal medical inventory needs. The award was competitively awarded with no set-aside designation, leveraging AmerisourceBergen's...
- The Defense Logistics Agency awarded a $12.76K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lidocaine 5% Patch 30S, with performance completion scheduled for September 9, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $3,450.57. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with performance required through September 9, 2025. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% patches (30-count units) with a ceiling value of $5,014.52. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $7,090.56, represents a non-competitive set-aside award and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $2,205.36 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% patches (30-count). This competitively awarded, firm fixed price contract is scheduled for completion by August 18, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $6.86K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lidocaine 5% Patch 30s, with final delivery due by September 9, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $2,551.95 under a firm fixed-price contract type. This non-set-aside award represents a routine pharmaceutical delivery fulfilling federal medical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5TCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lidocaine 5% patches (30-count units) under a firm fixed-price contract with a ceiling value of $2,886.03 and an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor contract running through December 2026 that supports pharmaceutical and medical supply needs across the Defense Health Agency and other federal healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The performance location for this delivery order is the company's corporate office in Conshohocken, Pennsylvania. As a child contract under the larger SPE2DX vehicle, this award exemplifies the company's ongoing role as a primary source for medical supply chain support to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/8/25 |